FAM53B Inhibitors
FAM53B inhibitors are a class of chemical compounds designed to target and attenuate the activity of the protein FAM53B. FAM53B, a factor associated with the regulation of cell proliferation, is implicated in various cellular processes including the modulation of cell cycle progression and maintenance of genomic stability. Inhibitors of this protein interfere with its function through a myriad of interactions at the molecular level, often by binding to the protein itself or by altering the cellular signaling pathways that regulate its activity. The precise action of these inhibitors depends on their chemical structure and the specific site on the FAM53B protein or associated pathways that they affect. By hindering the normal function of FAM53B, these inhibitors can influence the cellular proliferation rate and have an impact on the cell's internal signaling mechanisms that govern growth and division.
The biochemical action of FAM53B inhibitors involves the interruption of the protein's interaction with key partners in the intracellular milieu, which may include DNA, RNA, or other proteins that are essential for its function. The chemical compounds that make up this class of inhibitors are characterized by their ability to bind selectively to the FAM53B protein or to modulate the pathways that control its expression and activity. This specificity is crucial, as it ensures that the inhibitors exert their effects on the intended target without widespread disruption to other cellular functions. The inhibition of FAM53B can lead to alterations in gene expression profiles and disrupt the finely tuned balance of cellular proliferation signals. By limiting the activity of FAM53B, these inhibitors play a pivotal role in dictating the cellular response to various internal and external cues that would normally involve FAM53B's participation, thereby influencing the overall behavior and fate of the cell in which FAM53B is expressed.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, which can affect FAM53B by inhibiting phosphorylation events that may be necessary for its activity. By blocking these kinases, staurosporine indirectly prevents the activation of FAM53B that relies on phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that disrupts the PI3K/Akt pathway. Given that FAM53B may be involved in cell growth and survival pathways mediated by PI3K/Akt, the inhibition of this pathway could indirectly decrease the functional activity of FAM53B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor and can indirectly affect FAM53B activity by inhibiting downstream signaling pathways involved in cell cycle progression and growth, which could be pathways where FAM53B has a role. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine inhibits the Hedgehog signaling pathway. If FAM53B is involved in this pathway, cyclopamine could lead to reduced FAM53B function by preventing the pathway's activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK, which acts upstream of ERK in the MAPK pathway. Inhibition of MEK could result in reduced ERK-mediated phosphorylation events that may be required for FAM53B function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which could impede cellular stress response pathways. If FAM53B function is linked to these pathways, inhibition of JNK may lead to decreased functional activity of FAM53B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which may influence cellular responses to stress and inflammation. If FAM53B is involved in these responses, inhibition of p38 MAPK could indirectly decrease FAM53B activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, which could affect cell shape and motility. If FAM53B is implicated in pathways involving cytoskeletal rearrangement, inhibition of ROCK may indirectly inhibit FAM53B function. | ||||||
NF 449 | 389142-38-5 | sc-203159 | 10 mg | $314.00 | 5 | |
NF449 is a potent Gs alpha subunit-specific antagonist, potentially affecting cAMP-mediated signaling. If FAM53B operates within this pathway, NF449 could indirectly inhibit its activity by reducing cAMP levels. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, leading to suppression of the ERK pathway. If FAM53B requires ERK pathway activation for its functionality, U0126 could result in decreased FAM53B activity. | ||||||